Wells Fargo’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,782
| Closed | -$12.3K | – | 7925 |
|
|
2022
Q4 | $12.3K | Sell |
3,782
-1,094
| -22% | -$2.61K | ﹤0.01% | 5469 |
|
|
2022
Q3 | $14K | Sell |
4,876
-1
| -0% | -$3 | ﹤0.01% | 5560 |
|
|
2022
Q2 | $12K | Sell |
4,877
-296
| -6% | -$1.37K | ﹤0.01% | 5693 |
|
|
2022
Q1 | $42K | Sell |
5,173
-60
| -1% | -$613 | ﹤0.01% | 5743 |
|
|
2021
Q4 | $69K | Sell |
5,233
-10,716
| -67% | -$269K | ﹤0.01% | 5820 |
|
|
2021
Q3 | $695K | Buy |
15,949
+1,794
| +13% | +$77.4K | ﹤0.01% | 4472 |
|
|
2021
Q2 | $592K | Sell |
14,155
-698
| -5% | -$30.7K | ﹤0.01% | 4532 |
|
|
2021
Q1 | $719K | Sell |
14,853
-1,718
| -10% | -$100K | ﹤0.01% | 4471 |
|
|
2020
Q4 | $1.63M | Buy |
16,571
+6,526
| +65% | +$572K | ﹤0.01% | 3641 |
|
|
2020
Q3 | $693K | Buy |
10,045
+3,286
| +49% | +$287K | ﹤0.01% | 4119 |
|
|
2020
Q2 | $714K | Sell |
6,759
-1,403
| -17% | -$167K | ﹤0.01% | 4079 |
|
|
2020
Q1 | $725K | Buy |
8,162
+71
| +0.9% | +$8.46K | ﹤0.01% | 3755 |
|
|
2019
Q4 | $924K | Buy |
8,091
+185
| +2% | +$13.9K | ﹤0.01% | 3912 |
|
|
2019
Q3 | $489K | Buy |
7,906
+3,161
| +67% | +$253K | ﹤0.01% | 4402 |
|
|
2019
Q2 | $370K | Buy |
4,745
+1,168
| +33% | +$133K | ﹤0.01% | 4593 |
|
|
2019
Q1 | $482K | Buy |
3,577
+410
| +13% | +$43.1K | ﹤0.01% | 4359 |
|
|
2018
Q4 | $254K | Sell |
3,167
-372
| -11% | -$36.7K | ﹤0.01% | 4780 |
|
|
2018
Q3 | $372K | Buy |
3,539
+249
| +8% | +$23.7K | ﹤0.01% | 4641 |
|
|
2018
Q2 | $329K | Buy |
3,290
+12
| +0.4% | +$1.36K | ﹤0.01% | 4742 |
|
|
2018
Q1 | $414K | Buy |
3,278
+174
| +6% | +$27.1K | ﹤0.01% | 4534 |
|
|
2017
Q4 | $519K | Buy |
3,104
+1,417
| +84% | +$363K | ﹤0.01% | 4369 |
|
|
2017
Q3 | $531K | Buy |
1,687
+345
| +26% | +$109K | ﹤0.01% | 4287 |
|
|
2017
Q2 | $399K | Buy |
1,342
+1,175
| +704% | +$314K | ﹤0.01% | 4363 |
|
|
2017
Q1 | $38K | Sell |
167
-259
| -61% | -$44.7K | ﹤0.01% | 5539 |
|
|
2016
Q4 | $28K | Sell |
426
-1
| -0.2% | -$62 | ﹤0.01% | 5545 |
|
|
2016
Q3 | $28K | Sell |
427
-2,243
| -84% | -$145K | ﹤0.01% | 5508 |
|
|
2016
Q2 | $198K | Buy |
2,670
+2,066
| +342% | +$207K | ﹤0.01% | 4420 |
|
|
2016
Q1 | $68K | Sell |
604
-76
| -11% | -$8.61K | ﹤0.01% | 5093 |
|
|
2015
Q4 | $104K | Buy |
680
+490
| +258% | +$73.5K | ﹤0.01% | 4885 |
|
|
2015
Q3 | $20K | Sell |
190
-138
| -42% | -$17.9K | ﹤0.01% | 5545 |
|
|
2015
Q2 | $47K | Buy |
328
+250
| +321% | +$58K | ﹤0.01% | 5348 |
|
|
2015
Q1 | $26K | Buy |
78
+23
| +42% | +$8.18K | ﹤0.01% | 5277 |
|
|
2014
Q4 | $22K | Buy |
+55
| New | +$14.4K | ﹤0.01% | 5329 |
|
Other funds holding CALA
Wells Fargo's CALA Position: Q1 2023 in Review
Wells Fargo sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 3,782 shares — an estimated $12.3K sold.
Wells Fargo first reported a position in CALA in Q4 2014 and held it in 33 quarters. The position peaked at $1.63M in Q4 2020. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Wells Fargo reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Wells Fargo sold 3,782 Calithera Biosciences, Inc shares in Q1 2023, an estimated $12.3K.
- Wells Fargo first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 33 quarters.
- Wells Fargo's Calithera Biosciences, Inc position peaked at $1.63M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.